Qiagen N.V.
QIAGEN N.V.: Release of a capital market information

QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds

QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase

Release of a capital market information

Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to …

Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to the …